New research highlights the significance of dosage in haploinsufficiency related to osteogenesis imperfecta. This study provides insights that could influence future therapeutic strategies for this brittle bone disease.
dose matters haploinsufficiency in osteogenesis imperfecta
Original title: “Dose matters: haploinsufficiency in osteogenesis imperfecta.”